Clinical evaluation of transversus abdominis plane block and celecoxib after laparoscopic gastrectomy

Clinical evaluation of transversus abdominis plane block and celecoxib after laparoscopic gastrectomy - Evaluation of TAP block and celecoxib after laparoscopic gastrectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007457

Enrollment

Registered

2012-04-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer undergoing laparoscopic gastrectomy

Interventions

Intravenous fentanyl analgesia with transversus abdominis plane block and celecoxib Intravenous fentanyl analgesia with transversus abdominis plane block Intravenous fentanyl analgesia with celecoxib

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Gastric cancer undergoing laparoscopic gastrectomy 2) No distant metastasis 3) ASA-PS Class1-2 4) Obtained written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients having severe allergy 2) Case of emergency operation 3) Patients with drug addiction 4) Patients with dementia 5) Patients with severe psychological disease 6) Patients seems inadequate for this study by investigators

Design outcomes

Primary

Measure	Time frame
Postoperative pain relief	—

Secondary

Measure	Time frame
Adverse event	—

Countries

Japan

Contacts

Public ContactJunichi Fukui

Kansai Medical University Department of Surgery

fukuiju@hirakata.kmu.ac.jp072-804-0101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026